272 related articles for article (PubMed ID: 8498881)
21. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.
Sampson GA
Br J Psychiatry; 1979 Sep; 135():209-15. PubMed ID: 385093
[TBL] [Abstract][Full Text] [Related]
22. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
[TBL] [Abstract][Full Text] [Related]
23. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
24. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial.
Ramos MG; Hara C; Rocha FL
Int J Neuropsychopharmacol; 2009 Sep; 12(8):1081-8. PubMed ID: 19250561
[TBL] [Abstract][Full Text] [Related]
26. Treatment of premenstrual syndrome. A double-blind trial of dydrogesterone.
Dennerstein L; Morse C; Gotts G; Brown J; Smith M; Oats J; Burrows G
J Affect Disord; 1986; 11(3):199-205. PubMed ID: 2951407
[TBL] [Abstract][Full Text] [Related]
27. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
Young SA; Hurt PH; Benedek DM; Howard RS
J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
[TBL] [Abstract][Full Text] [Related]
28. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
29. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
[TBL] [Abstract][Full Text] [Related]
30. Medical management of premenstrual dysphoric disorder.
Yonkers KA
J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
[TBL] [Abstract][Full Text] [Related]
31. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
32. Essential fatty acids in the treatment of premenstrual syndrome.
Collins A; Cerin A; Coleman G; Landgren BM
Obstet Gynecol; 1993 Jan; 81(1):93-8. PubMed ID: 8416468
[TBL] [Abstract][Full Text] [Related]
33. Fluoxetine in the treatment of premenstrual syndrome.
Stone AB; Pearlstein TB; Brown WA
Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Freeman EW
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
[TBL] [Abstract][Full Text] [Related]
35. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S
BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889
[TBL] [Abstract][Full Text] [Related]
36. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome.
Stevinson C; Ernst E
BJOG; 2000 Jul; 107(7):870-6. PubMed ID: 10901558
[TBL] [Abstract][Full Text] [Related]
37. Calcium supplementation in premenstrual syndrome: a randomized crossover trial.
Thys-Jacobs S; Ceccarelli S; Bierman A; Weisman H; Cohen MA; Alvir J
J Gen Intern Med; 1989; 4(3):183-9. PubMed ID: 2656936
[TBL] [Abstract][Full Text] [Related]
38. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
39. Variable dosing of sertraline for premenstrual exacerbation of depression: a pilot study.
Miller MN; Newell CL; Miller BE; Frizzell PG; Kayser RA; Ferslew KE
J Womens Health (Larchmt); 2008; 17(6):993-7. PubMed ID: 18681820
[TBL] [Abstract][Full Text] [Related]
40. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
